查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1574950

胜肽抗生素市場，按產品類型、疾病、給藥途徑、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Peptide Antibiotics Market, By Product Type, By Disease, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，胜肽類抗生素市場規模為48.0409億美元，2024年至2032年複合年成長率為11.20%。

多肽抗生素市場-市場動態

抗生素抗藥性的增加推動了對胜肽抗生素創新的需求。

抗生素抗藥性的上升是一個大問題，增加了對肽類抗生素的需求。根據美國疾病管制與預防中心 (CDC) 的數據，美國每年有超過 280 萬例抗生素抗藥性感染，導致超過 35,000 人死亡。這是一個嚴重的問題，顯示我們需要新的治療方法，因為許多常見的抗生素不再有效。

胜肽抗生素可能是個很好的解決方案。它們的作用與普通抗生素不同，研究人員正在研究它們的特殊功能以對抗抗生素抗藥性。這些獨特的特性使胜肽抗生素能夠有效對抗抗藥性細菌，讓我們希望找到更好的方法來控制感染。

肽類抗生素市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 11.20% 左右的複合年成長率成長

根據產品類型細分，預計核醣體合成胜肽抗生素將在 2023 年呈現最大市場佔有率

按疾病細分，2023年皮膚感染為主導類型

根據給藥途徑細分，注射劑是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

胜肽抗生素市場-細分分析：

全球胜肽抗生素市場根據產品類型、疾病、給藥途徑和地區進行細分。

根據產品類型，市場分為兩類：核醣體合成胜肽抗生素和非核醣體合成胜肽抗生素。核醣體合成胜肽抗生素是最突出的部分。這主要是因為它們可以很好地抵抗各種感染，尤其是由革蘭氏陽性菌引起的感染。它們通常更容易口服，這使得患者更有可能接受治療。隨著抗生素抗藥性細菌的興起，人們對這些抗生素進行了更多的研究，從而產生了新的有效選擇。它們治療嚴重感染的能力使它們成為市場的關鍵部分，使醫生和患者受益。

市場依疾病分為兩類：皮膚感染、HABP/VABP、血流感染和其他。皮膚感染部分最為突出。皮膚感染很常見，可由多種細菌引起，因此有效的治療至關重要。胜肽抗生素被經常使用，因為它們可以有效地針對這些細菌。由於皮膚感染很普遍，如果不及時治療可能會導致更嚴重的併發症，因此對這些抗生素的需求強勁。這種對治療皮膚感染的關注有助於推動市場成長，並為醫療保健提供者和患者提供支援。

多肽抗生素市場-地理洞察

北美的胜肽類抗生素市場正在快速成長。這一成長是由於對抗抗藥性細菌的新型抗生素的需求不斷增加。許多醫院和醫療保健提供者正在尋找有效的治療方法。該領域的研究和開發正在獲得更多資金，這有助於創造新的胜肽抗生素。

此外，醫生和患者對這些治療方法益處的認知正在傳播。該市場也得到鼓勵創新的監管框架的支持。總體而言，北美正在成為胜肽抗生素產業的關鍵參與者。

多胜肽抗生素市場-競爭格局：

胜肽抗生素市場競爭激烈，百特國際、諾華和默克等主要參與者處於領先地位。這些公司專注於開發新型有效的抗生素來應對日益成長的抗藥性。阿斯特捷利康（AstraZeneca）和勃林格殷格翰（Boehringer Ingelheim）等其他公司也投資研究以創新和改進其產品。 Sandoz 和 Hikma Pharmaceuticals 專注於學名藥，使治療更容易獲得。同時，安進和吉利德科學專注於獨特的療法，以滿足特定的醫療需求。總體而言，這些公司正在努力透過合作、研究和擴大產品線來增強自己的地位，以應對全球健康挑戰。

最新進展：

2024 年 9 月，安捷倫科技公司完成了對 BIOVECTRA 的收購，BIOVECTRA 是一家加拿大合約開發和製造組織 (CDMO)，專注於生物製劑、高效活性藥物成分和其他用於標靶治療的化合物。

2024年8月，Bora Pharmaceuticals Co., Ltd.策略投資Tanvex Biopharma Co., Ltd.。 作為此次合作的一部分，Bora旗下專注於大分子CDMO的子公司Bora Biologics將其生物製造設施與Tanvex合併，成立Tanvex Biopharma Co., Ltd.。

目錄

第 1 章：胜肽抗生素市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的胜肽抗生素市場片段
    • 按疾病分類的胜肽抗生素市場片段
    • 依給藥途徑分類的胜肽抗生素市場片段
    • 按國家/地區分類的胜肽抗生素市場片段
    • 按地區分類的胜肽抗生素市場片段
  • 競爭洞察

第 3 章：胜肽抗生素主要市場趨勢

  • 肽抗生素市場促進因素
    • 市場促進因素的影響分析
  • 肽類抗生素市場限制
    • 市場限制影響分析
  • 肽類抗生素市場機會
  • 多肽抗生素市場未來趨勢

第 4 章：胜肽抗生素產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：胜肽抗生素市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：胜肽抗生素市場格局

  • 2023年肽類抗生素市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：胜肽抗生素市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 核醣體合成胜肽抗生素
    • 非核醣體合成胜肽抗生素

第 8 章：胜肽抗生素市場 - 按疾病分類

  • 概述
    • 按疾病分類的細分市場佔有率分析
    • 皮膚感染
    • HABP/VABP
    • 血流感染
    • 其他

第 9 章：胜肽抗生素市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 口服
    • 可注射
    • 專題
    • 其他

第 10 章：胜肽抗生素市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美肽類抗生素主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模與預測（按疾病）
    • 北美市場規模與預測（按管理途徑）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲胜肽類抗生素主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按疾病）
    • 歐洲市場規模與預測（按管理途徑）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區胜肽類抗生素主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按疾病）
    • 亞太地區市場規模與預測（依管理途徑）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲肽類抗生素主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按疾病）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲胜肽類抗生素主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按疾病）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析-胜肽抗生素產業

  • 競爭儀表板
  • 公司簡介
    • Baxter International Inc.
    • Novartis AG
    • Merck & Co., Inc.
    • AstraZeneca PLC
    • Boehringer Ingelheim GmbH
    • Fujifilm Diosynth Biotechnologies
    • Hikma Pharmaceuticals PLC
    • Polymun Scientific GmbH
    • Sandoz International GmbH (a Novartis division)
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Amgen Inc.
    • Gilead Sciences, Inc.
    • Hoffmann-La Roche Ltd.
    • Vitae Pharmaceuticals, Inc.
    • Thermo Fisher Scientific Inc.
    • CureVac AG

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3953

REPORT HIGHLIGHT

Peptide Antibiotics Market size was valued at USD 4,804.09 Million in 2023, expanding at a CAGR of 11.20% from 2024 to 2032.

The peptide antibiotics market involves the development and sale of antibiotics made from small proteins called peptides. These antibiotics are effective against bacteria and can help treat infections, especially those resistant to traditional antibiotics. The market is growing due to increasing bacterial resistance and the need for new treatments. Researchers are exploring different peptides to find new drugs that are safe and effective. This area of medicine is important for public health as it offers hope in the fight against stubborn infections. Overall, peptide antibiotics represent a promising solution in the battle against antibiotic resistance.

Peptide Antibiotics Market- Market Dynamics

Increasing antibiotic resistance drives demand for peptide antibiotics innovation.

The rise of antibiotic resistance is a big problem that is increasing the demand for peptide antibiotics. According to the Centers for Disease Control and Prevention (CDC), there are more than 2.8 million antibiotic-resistant infections in the U.S. every year, leading to over 35,000 deaths. This is a serious issue and shows we need new treatments because many common antibiotics no longer work well.

Peptide antibiotics could be a good solution. They work differently than regular antibiotics, and researchers are looking into their special features to fight antibiotic resistance. These unique properties make peptide antibiotics effective against resistant bacteria, giving us hope for better ways to control infections.

Peptide Antibiotics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.20% over the forecast period (2024-2032)

Based on product type segmentation, Ribosomal Synthesized Peptide Antibiotics was predicted to show maximum market share in the year 2023

Based on Disease segmentation, Skin Infection was the leading type in 2023

Based on Route of Administration segmentation, Injectables was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Peptide Antibiotics Market- Segmentation Analysis:

The Global Peptide Antibiotics Market is segmented based on Product Type, Disease, Route of Administration, and Region.

The market is divided into two categories based on Product Type: Ribosomal Synthesized Peptide Antibiotics, and Non-Ribosomal Synthesized Peptide Antibiotics. Ribosomal Synthesized Peptide Antibiotics are the most prominent segment. This is mainly because they work well against various infections, especially those caused by Gram-positive bacteria. They are often easier to take by mouth, which makes patients more likely to follow their treatment. With the rise of antibiotic-resistant bacteria, more research is being done on these antibiotics, leading to new and effective options. Their ability to treat serious infections makes them a key part of the market, benefiting both doctors and patients.

The market is divided into two categories based on Disease: Skin Infection, HABP/VABP, Blood Stream Infection, and Others. The skin infection segment is the most prominent. Skin infections are common and can be caused by a variety of bacteria, making effective treatments essential. Peptide antibiotics are frequently used because they effectively target these bacteria. Since skin infections are widespread and can lead to more serious complications if left untreated, there is a strong demand for these antibiotics. This focus on treating skin infections helps drive growth in the market and supports both healthcare providers and patients.

Peptide Antibiotics Market- Geographical Insights

The peptide antibiotics market in North America is growing rapidly. This rise is due to the increasing need for new antibiotics to fight drug-resistant bacteria. Many hospitals and healthcare providers are looking for effective treatments. Research and development in this area are getting more funding, which helps create new peptide antibiotics.

Moreover, awareness of the benefits of these treatments is spreading among doctors and patients. The market is also supported by regulatory frameworks that encourage innovation. Overall, North America is becoming a key player in the peptide antibiotics industry.

Peptide Antibiotics Market- Competitive Landscape:

The peptide antibiotics market is highly competitive, with key players like Baxter International, Novartis, and Merck leading the way. These companies focus on developing new and effective antibiotics to tackle rising resistance. Others, like AstraZeneca and Boehringer Ingelheim, also invest in research to innovate and improve their product offerings. Sandoz and Hikma Pharmaceuticals specialize in generics, making treatments more accessible. Meanwhile, Amgen and Gilead Sciences focus on unique therapies to meet specific medical needs. Overall, these companies are striving to enhance their positions through collaboration, research, and expanding their product lines to address global health challenges.

Recent Developments:

In September 2024, Agilent Technologies Inc. finalized its acquisition of BIOVECTRA, a Canadian contract development and manufacturing organization (CDMO) that focuses on biologics, highly potent active pharmaceutical ingredients, and other compounds for targeted therapies.

In August 2024, Bora Pharmaceuticals Co., Ltd. strategically invested in Tanvex Biopharma Co., Ltd. As part of this partnership, Bora Biologics, a subsidiary of Bora that specializes in large molecule CDMO, will merge its biomanufacturing facilities with Tanvex to establish a global service for the development and supply of biologics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PEPTIDE ANTIBIOTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Baxter International Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Fujifilm Diosynth Biotechnologies
  • Hikma Pharmaceuticals PLC
  • Polymun Scientific GmbH
  • Sandoz International GmbH (a Novartis division)
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Amgen Inc.
  • Gilead Sciences, Inc.
  • Hoffmann-La Roche Ltd.
  • Vitae Pharmaceuticals, Inc.
  • Thermo Fisher Scientific Inc.
  • CureVac AG

GLOBAL PEPTIDE ANTIBIOTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Ribosomal Synthesized Peptide Antibiotics
  • Non-Ribosomal Synthesized Peptide Antibiotics

GLOBAL PEPTIDE ANTIBIOTICS MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Skin Infection
  • HABP/VABP
  • Blood Stream Infection
  • Others

GLOBAL PEPTIDE ANTIBIOTICS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable
  • Topical
  • Others

GLOBAL PEPTIDE ANTIBIOTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Peptide Antibiotics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Peptide Antibiotics Market Snippet by Product Type
    • 2.1.2. Peptide Antibiotics Market Snippet by Disease
    • 2.1.3. Peptide Antibiotics Market Snippet by Route of Administration
    • 2.1.4. Peptide Antibiotics Market Snippet by Country
    • 2.1.5. Peptide Antibiotics Market Snippet by Region
  • 2.2. Competitive Insights

3. Peptide Antibiotics Key Market Trends

  • 3.1. Peptide Antibiotics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Peptide Antibiotics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Peptide Antibiotics Market Opportunities
  • 3.4. Peptide Antibiotics Market Future Trends

4. Peptide Antibiotics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Peptide Antibiotics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Peptide Antibiotics Market Landscape

  • 6.1. Peptide Antibiotics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Peptide Antibiotics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Ribosomal Synthesized Peptide Antibiotics
    • 7.1.3. Non-Ribosomal Synthesized Peptide Antibiotics

8. Peptide Antibiotics Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 8.1.2. Skin Infection
    • 8.1.3. HABP/VABP
    • 8.1.4. Blood Stream Infection
    • 8.1.5. Others

9. Peptide Antibiotics Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Oral
    • 9.1.3. Injectable
    • 9.1.4. Topical
    • 9.1.5. Others

10. Peptide Antibiotics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Peptide Antibiotics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Peptide Antibiotics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Peptide Antibiotics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Peptide Antibiotics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Peptide Antibiotics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Peptide Antibiotics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Baxter International Inc.
    • 11.2.2. Novartis AG
    • 11.2.3. Merck & Co., Inc.
    • 11.2.4. AstraZeneca PLC
    • 11.2.5. Boehringer Ingelheim GmbH
    • 11.2.6. Fujifilm Diosynth Biotechnologies
    • 11.2.7. Hikma Pharmaceuticals PLC
    • 11.2.8. Polymun Scientific GmbH
    • 11.2.9. Sandoz International GmbH (a Novartis division)
    • 11.2.10. Bristol-Myers Squibb Company
    • 11.2.11. Eli Lilly and Company
    • 11.2.12. Amgen Inc.
    • 11.2.13. Gilead Sciences, Inc.
    • 11.2.14. Hoffmann-La Roche Ltd.
    • 11.2.15. Vitae Pharmaceuticals, Inc.
    • 11.2.16. Thermo Fisher Scientific Inc.
    • 11.2.17. CureVac AG

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us